EUVIMEDEUVIMED entdecken
Multizentrische Studie

Longitudinal outcomes following international multicentre experience with robotic aortic valve replacement

Lawrence M Wei, Daniel Pereda iD, Danny Ramzy, Feras H Khaliel, Ghulam Murtaza, James Hunter Mehaffey, Nai-Hsin Chi, Robinson Poffo, Štěpán Černý, Jan Vojáček, Tristan D Yan, Serguei Melnitchouk und 9 weitere

European Journal of Cardio-Thoracic Surgery · 28.03.2025 · 67 (4)

DOI: 10.1093/ejcts/ezaf103 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 25.03.2025. Verfasst von Lawrence M Wei und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, USA. Hauptthemen laut MEDLINE: Aortic Valve, Robotic Surgical Procedures, Heart Valve Prosthesis Implantation, Aortic Valve Stenosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Insitute of Health National Heart Lung Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives In an effort to maintain the technical aspects of traditional prosthetic surgical aortic valve replacement (AVR) while reducing invasiveness and facilitate options for concomitant operations, transaxillary lateral mini-thoracotomy endoscopic robotic-assisted aortic valve replacement (RAVR) has been introduced. The present data highlight the contemporary international collaborative experience. METHODS All consecutive patients undergoing standardized RAVR across 10 international sites (1/2020–7/2024) were evaluated using a central database with 1 year follow-up. RESULTS A total of 300 patients were analysed with a median predicted risk of 1.6% with aortic stenosis in 85.7%, nearly half with bicuspid valves. Biological prostheses were implanted in 220 (73.3%) with a median valve size 23 mm, 10% receiving aortic root enlargement, with 17% of all patients undergoing concomitant procedures. Median cross-clamp 120 min with no conversions to sternotomy. Median length of stay was 5 days, 4.3% with prolonged ventilation, 1.7% renal failure, 1.0% stroke and 8.3% required re-thoracotomy for evacuation of haemothorax. There were two 30-day operative mortalities (0.7%). The new permanent pacemaker rate for the full cohort was 2.6%. Of 163 patients with complete 1-year clinical and echocardiographic follow-up, mean aortic valve gradient was 10 mmHg and all but 2 patients (1.2%) had trace to no prosthetic or paravalvular insufficiency. CONCLUSIONS RAVR is safe and effective, providing the reproducible benefits of surgical AVR while affording a less invasive approach that permits the opportunity for concomitant procedures. For low and intermediate risk patients with aortic valve disease, RAVR is a potential reproducible alternative for patients and heart teams.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic ValveRobotic Surgical ProceduresHeart Valve Prosthesis ImplantationAortic Valve StenosisHumansMaleFemaleAgedTreatment OutcomeMiddle AgedAged, 80 and overHeart Valve ProsthesisFollow-Up StudiesThoracotomyLongitudinal Studies

Stichwörter der Autor:innen

Robotic valve surgeryRobotic-assisted aortic valve replacement

Autor:innen und Institutionen

  • Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV, USA.
  • Department of Cardiovascular Surgery, University of Barcelona, Barcelona, Spain.
  • Division of Cardiac Surgery, McGovern Medical School, UTHealth, Houston, TX, USA.
  • Division of Cardiac Surgery, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Division of Cardiothoracic Surgery, SSM Health St Mary's Hospital, Madison, WI, USA.
  • Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.

ORCID-Profile: Daniel Pereda, Arman Arghami, Vinay Badhwar

Förderung

  • National Insitute of Health National Heart Lung Blood Institute

Zitieren

APA

Wei, L. M., Pereda, D., Ramzy, D., Khaliel, F. H., Murtaza, G., Mehaffey, J. H., Chi, N. H., Poffo, R., Černý, Š., Vojáček, J., Yan, T. D., Melnitchouk, S., Weber, A. C., Smith, R. L., Raikar, G. V., Darehzereshki, A., Geirsson, A., Arghami, A., Navia, J. L., …, & Badhwar, V. (2025). Longitudinal outcomes following international multicentre experience with robotic aortic valve replacement. European Journal of Cardio-Thoracic Surgery, 67(4). https://doi.org/10.1093/ejcts/ezaf103

Vancouver

Wei LM, Pereda D, Ramzy D, Khaliel FH, Murtaza G, Mehaffey JH, et al. Longitudinal outcomes following international multicentre experience with robotic aortic valve replacement. European Journal of Cardio-Thoracic Surgery. 2025;67(4). doi:10.1093/ejcts/ezaf103

BibTeX
@article{Wei2025,
  author = {Wei, Lawrence M and Pereda, Daniel and Ramzy, Danny and Khaliel, Feras H and Murtaza, Ghulam and Mehaffey, James Hunter and Chi, Nai-Hsin and Poffo, Robinson and Černý, Štěpán and Vojáček, Jan and Yan, Tristan D and Melnitchouk, Serguei and Weber, Alberto C and Smith, Robert L and Raikar, Goya V and Darehzereshki, Ali and Geirsson, Arnar and Arghami, Arman and Navia, Jose L and Bonatti, Johannes and Badhwar, Vinay},
  title = {Longitudinal outcomes following international multicentre experience with robotic aortic valve replacement},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  volume = {67},
  number = {4},
  doi = {10.1093/ejcts/ezaf103}
}
Kostenlos starten →